BSECompany Update6d ago · 3 Nov 2026, 11:31 am
Gland Pharma receives approval for Methylprednisolone Acetate Injectable Suspension USP, Single Dose and Multiple Dose Vials
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveOrder Win
Gland Pharma receives approval from USFDA for Methylprednisolone Acetate Injectable Suspension USP, Single-Dose and Multiple-Dose Vials, with potential US sales of approximately USD 214 million.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release